TY  - JOUR
AU  - Perez-Robles, Raquel
AU  - Salmeron-Garcia, Antonio
AU  - Clemente-Bautista, Susana
AU  - Jimenez-Lozano, Ines
AU  - Cabañas-Poy, Maria Josep
AU  - Cabeza, Jose
AU  - Navas, Natalia
PY  - 2022
DO  - 10.1039/d2ay01254e
UR  - http://hdl.handle.net/10668/19643
T2  - Analytical methods : advancing methods and applications
AB  - Teduglutide (Revestive®, 10 mg mL-1) is a recombinant human glucagon-like peptide 2 analogue, used in the treatment of short bowel syndrome, a serious and highly disabling condition which results from either too small a length of intestine or loss of...
LA  - en
PB  - Royal Society of Chemistry
KW  - Humans
KW  - Chromatography, High Pressure Liquid
KW  - Short Bowel Syndrome
KW  - Glucagon-Like Peptide 2
KW  - Peptides
KW  - Teduglutide
KW  - Limit of Detection
KW  - Intestines
KW  - Pharmaceutical Preparations
KW  - Hospitals
TI  - Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS.
TY  - research article
VL  - 14
ER  -